keyword
https://read.qxmd.com/read/38683653/changes-in-the-clinical-practice-of-mental-health-service-providers-throughout-the-covid-19-pandemic-longitudinal-questionnaire-study
#1
JOURNAL ARTICLE
Milena Gotra, Katharine Lindberg, Nicholas Jasinski, David Scarisbrick, Shannon Reilly, Jonathan Perle, Liv Miller, James Mahoney Iii
BACKGROUND: The COVID-19 pandemic impacted the practices of most mental health providers and resulted in a rapid transition to providing telemental health services, changes that were likely related to stay-at-home policies as well as increased need for services. OBJECTIVE: The aim of this study was to examine whether these changes to practice have been sustained over time throughout the course of the COVID-19 pandemic and whether there are differences among mental health provider type and setting...
April 29, 2024: JMIR Formative Research
https://read.qxmd.com/read/38596857/real-world-study-on-the-use-of-pegylated-interferon-alpha-2a-for-treatment-of-mycosis-fungoides-s%C3%A3-zary-syndrome-using-time-to-next-treatment-as-a-measure-of-clinical-benefit-an-eortc-cltg-study
#2
JOURNAL ARTICLE
Keila Mitsunaga, Martine Bagot, Caroline Ram-Wolff, Emmanuella Guenova, Christina von Gugelberg, Emmilia Hodak, Iris Amitay-Laish, Evangelia Papadavid, Constanze Jonak, Stefanie Porkert, Julia Scarisbrick, Rona Applewaite, Marie Beylot-Barry, Jan Nicolay, Pietro Quaglino, José Antonio Sanches, Jade Cury-Martins, David Lora-Pablos, Pablo Ortiz
INTRODUCTION: Mycosis fungoides (MF) and Sézary syndrome (SS) are chronic malignant diseases that typically necessitate diverse strategies to achieve remission. Systemic interferon alpha (IFN-α, subtypes 2a and 2b) has been used for MF/SS since 1984, however its production was recently stopped and so the recombinant pegylated (PEG) form of IFN α-2a remains as single IFN alternative treatment, even though not approved for MF/SS. OBJECTIVE: To assess effectiveness and safety of PEG IFN α-2a in monotherapy and in combination with other treatments using time to next treatment (TTNT) as a measure of clinical therapeutic benefit in real world setting...
April 10, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38595050/paediatric-onset-lymphomatoid-papulosis-results-of-a-multicentre-retrospective-cohort-study-on-behalf-of-the-eortc-cutaneous-lymphoma-tumours-group-cltg
#3
JOURNAL ARTICLE
Maël Blanchard, Marie-Anne Morren, Anne-Marie Busschots, Esther Hauben, Silvia Alberti-Violetti, Emilio Berti, Gianluca Avallone, Gianluca Tavoletti, Michele Panzone, Pietro Quaglino, Cristiana Colonna, Rutger C Melchers, Maarten H Vermeer, Robert Gniadecki, Christina Mitteldorf, Janika Gosmann, Rudolf Stadler, Constanze Jonak, Meital Oren-Shabtai, Emmilia Hodak, Rivka Friedland, Emily Gordon, Larisa J Geskin, Julia J Scarisbrick, Fatima Mayo Martínez, Lucero Noguera Morel, Kevin Pehr, Boyko Amarov, Mohamed Faouzi, Jan P Nicolay, Werner Kempf, Gabriela Blanchard, Emmanuella Guenova
BACKGROUND: Lymphomatoid Papulosis (LyP) is a rare cutaneous T-cell lymphoproliferative disorder. Comprehensive data on LyP in the paediatric population is scarce. OBJECTIVES: To characterize epidemiological, clinical, histopathological, and prognostic features of paediatric LyP. METHODS: This was a retrospective, multicentre international cohort study including 87 cases of children and adolescents with LyP diagnosed between 1998 and 2022...
April 10, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38581201/classifications-of-cutaneous-lymphomas-and-lymphoproliferative-disorders-an-update-from-the-eortc-cutaneous-lymphoma-histopathology-group
#4
REVIEW
W Kempf, C Mitteldorf, L Cerroni, R Willemze, E Berti, E Guenova, J J Scarisbrick, M Battistella
The classification of primary cutaneous lymphomas and lymphoproliferative disorders (LPD) is continuously evolving by integrating novel clinical, pathological and molecular data. Recently two new classifications for haematological malignancies including entities of cutaneous lymphomas were proposed: the 5th edition of the WHO classification of haematolymphoid tumours and the International Consensus Classification (ICC) of mature lymphoid neoplasms. This article provides an overview of the changes introduced in these two classifications compared to the previous WHO classification...
April 6, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/38576352/cutaneous-t-cell-lymphoma-care-across-europe-insights-from-the-horizon-project
#5
JOURNAL ARTICLE
Gabriele Roccuzzo, Joana Calvão, Gabor Dobos, Erika Morsia, Pablo Mozas, Elizabeth Peterknecht, Anne M R Schrader, Francesca Zottarelli, Martine Bagot, Rudolf Stadler, Maarten Vermeer, Pietro Quaglino, Julia Scarisbrick
No abstract text is available yet for this article.
April 5, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38169447/parting-neuroinflammation-with-protease-activated-receptor-2-pepducins
#6
JOURNAL ARTICLE
Isobel A Scarisbrick
No abstract text is available yet for this article.
January 2, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/38043039/bridging-the-specialty-gap-update-on-primary-cutaneous-lymphomas
#7
JOURNAL ARTICLE
Elise A Olsen, Emmilia Hodak, Larisa Geskin, Julia Scarisbrick
No abstract text is available yet for this article.
November 30, 2023: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/37890355/eortc-consensus-recommendations-for-the-treatment-of-mycosis-fungoides-s%C3%A3-zary-syndrome-update-2023
#8
REVIEW
Johanna Latzka, Chalid Assaf, Martine Bagot, Antonio Cozzio, Reinhard Dummer, Emmanuella Guenova, Robert Gniadecki, Emmilia Hodak, Constanze Jonak, Claus-Detlev Klemke, Robert Knobler, Stephen Morrris, Jan P Nicolay, Pablo L Ortiz-Romero, Evangelia Papadavid, Nicola Pimpinelli, Pietro Quaglino, Annamari Ranki, Julia Scarisbrick, Rudolf Stadler, Liisa Väkevä, Maarten H Vermeer, Ulrike Wehkamp, Sean Whittaker, Rein Willemze, Franz Trautinger
On behalf of the EORTC Cutaneous Lymphoma Tumours Group (EORTC-CLTG) and following up on earlier versions published in 2006 and 2017 this document provides an updated standard for the treatment of mycosis fungoides and Sézary syndrome (MF/SS). It considers recent relevant publications and treatment options introduced into clinical practice after 2017. Consensus was established among the authors through a series of consecutive consultations in writing and a round of discussion. Treatment options are assigned to each disease stage and, whenever possible and clinically useful, separated into first- and second line options annotated with levels of evidence...
December 2023: European Journal of Cancer
https://read.qxmd.com/read/37822710/elevated-biomarkers-of-neural-injury-in-older-adults-following-head-down-bed-rest-links-to-cardio-postural-deconditioning-with-spaceflight-and-aging
#9
JOURNAL ARTICLE
Andrew P Blaber, Farshid Sadeghian, Donya Naz Divsalar, Isobel A Scarisbrick
INTRODUCTION: Prolonged physical inactivity with bed rest or spaceflight is associated with cardiovascular and neuromuscular deconditioning; however, its impact on neural integrity of cardio-postural reflexes and possible mitigation with exercise has not been examined. We assessed the association between the physiological deconditioning of bed rest immobilization with neural injury markers and the effects of 60-75 min of daily exercise. METHODS: Data were collected as part of a randomized clinical trial (clinicaltrials...
2023: Frontiers in Human Neuroscience
https://read.qxmd.com/read/37802679/evaluating-response-trends-of-chlormethine-mechlorethamine-gel-in-patients-with-stage-i-iia-mycosis-fungoides-analysis-of-individual-patient-data-from-a-randomized-controlled-phase-ii-study-to-facilitate-optimal-treatment-experiences
#10
JOURNAL ARTICLE
Larisa J Geskin, James T Angello, Martine Bagot, Emmanuella Guenova, Neda Nikbakht, Christiane Querfeld, Julia J Scarisbrick
INTRODUCTION: Chlormethine (CL) gel was approved for treatment of mycosis fungoides based on the pivotal 201 trial (NCT00168064). Data visualization from individual patients is a powerful tool for discovery of hidden treatment trends. Here, we present a post hoc analysis of individual patient data from the pivotal trial to provide a more granular depiction of treatment and response changes over time, with an emphasis on end of treatment status. MATERIALS AND METHODS: Individual patient response data were plotted over a 12-month treatment period to visualize patient experiences while using CL gel...
September 7, 2023: Clinical Lymphoma, Myeloma & Leukemia
https://read.qxmd.com/read/37685514/noninvasive-neuromodulation-in-parkinson-s-disease-insights-from-animal-models
#11
REVIEW
Katherine Muksuris, David M Scarisbrick, James J Mahoney, Mariya V Cherkasova
The mainstay treatments for Parkinson's Disease (PD) have been limited to pharmacotherapy and deep brain stimulation. While these interventions are helpful, a new wave of research is investigating noninvasive neuromodulation methods as potential treatments. Some promising avenues have included transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), electroconvulsive therapy (ECT), and focused ultrasound (FUS). While these methods are being tested in PD patients, investigations in animal models of PD have sought to elucidate their therapeutic mechanisms...
August 22, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37648672/international-study-of-treatment-efficacy-in-ss-shows-superiority-of-combination-therapy-and-heterogeneity-of-treatment-strategies
#12
JOURNAL ARTICLE
Belinda A Campbell, Gabor Dobos, Zahra Haider, H Miles Prince, Martine Bagot, Felicity Evison, Carrie van der Weyden, Chris McCormack, Caroline Ram-Wolff, Maryam Miladi, Julia J Scarisbrick
Despite increasing availability of therapies, patients with Sezary syndrome (SS) commonly endure multi-line treatment journeys, mostly with partial responses of short duration. Measuring clinical benefit is challenging; time-to-next-treatment (TTNT) provides a robust, objective measurement of efficacy. This international observational study examines patterns of clinical care and therapeutic benefit as measured by TTNT. TTNT was calculated for monotherapies and combination therapies, with consideration to treatment line...
November 14, 2023: Blood Advances
https://read.qxmd.com/read/37644477/cerebrospinal-fluid-camk2a-levels-at-baseline-predict-long-term-progression-in-multiple-sclerosis
#13
JOURNAL ARTICLE
Dorsa Sohaei, Simon Thebault, Lisa M Avery, Ihor Batruch, Brian Lam, Wei Xu, Rubah S Saadeh, Isobel A Scarisbrick, Eleftherios P Diamandis, Ioannis Prassas, Mark S Freedman
BACKGROUND: Multiple sclerosis (MS) remains a highly unpredictable disease. Many hope that fluid biomarkers may contribute to better stratification of disease, aiding the personalisation of treatment decisions, ultimately improving patient outcomes. OBJECTIVE: The objective of this study was to evaluate the predictive value of CSF brain-specific proteins from early in the disease course of MS on long term clinical outcomes. METHODS: In this study, 34 MS patients had their CSF collected and stored within 5 years of disease onset and were then followed clinically for at least 15 years...
August 29, 2023: Clinical Proteomics
https://read.qxmd.com/read/37290364/post-traumatic-stress-disorder-and-traumatic-events-in-china-a-nationally-representative-cross-sectional-epidemiological-study
#14
JOURNAL ARTICLE
Weihui Li, Peng Cheng, Zhaorui Liu, Chao Ma, Bangshan Liu, Wanhong Zheng, Dave Scarisbrick, Jin Lu, Lingjiang Li, Yueqin Huang, Limin Wang, Yongping Yan, Shuiyuan Xiao, Yan Zhang, Tingting Zhang, Jie Yan, Yaqin Yu, Xiufeng Xu, Zhizhong Wang, Yifeng Xu, Tao Li, Guangming Xu, Xiangdong Xu, Meihua Xue, Guohua Li, Fujun Jia, Jianfei Shi, Ning Zhang, Xinbai Du, Hong Sang, Congpei Zhang, Bo Liu
Post-traumatic stress disorder (PTSD) is one of the most severe sequelae of trauma. But a nationally representative epidemiological data for PTSD and trauma events (TEs) was unavailable in China. This article firstly demonstrated detailed epidemiological information on PTSD, TEs, and related comorbidities in the national-wide community-based mental health survey in China. A total of 9,378 participants completed the PTSD-related interview of the CIDI 3.0. Lifetime prevalence and 12-month prevalence of PTSD in total respondents were 0...
June 3, 2023: Psychiatry Research
https://read.qxmd.com/read/37177894/skin-swabs-in-the-skin-lymphoma-clinic-from-swab-to-treatment
#15
JOURNAL ARTICLE
Elizabeth Peterknecht, Julia Scarisbrick
No abstract text is available yet for this article.
May 13, 2023: British Journal of Dermatology
https://read.qxmd.com/read/36788117/quantitation-of-neurofilament-light-chain-protein-in-serum-and-cerebrospinal-fluid-from-patients-with-multiple-sclerosis-using-the-msd-r-plex-nfl-assay
#16
JOURNAL ARTICLE
Antigona Ulndreaj, Dorsa Sohaei, Simon Thebault, Oscar D Pons-Belda, Amaia Fernandez-Uriarte, Christopher Campbell, David Cheo, Martin Stengelin, George Sigal, Mark S Freedman, Isobel A Scarisbrick, Ioannis Prassas, Eleftherios P Diamandis
OBJECTIVES: Neurofilament light (NfL) chain is a marker of neuroaxonal damage in various neurological diseases. Here we quantitated NfL levels in the cerebrospinal fluid (CSF) and serum from patients with multiple sclerosis (MS) and controls, using the R-PLEX NfL assay, which employs advanced Meso Scale Discovery® (MSD) electrochemiluminescence (ECL)-based detection technology. METHODS: NfL was quantitated in samples from 116 individuals from two sites (Ottawa Hospital Research Institute and Mayo Clinic), consisting of patients with MS (n=71) and age- and sex-matched inflammatory neurological controls (n=13) and non-inflammatory controls (n=32)...
February 15, 2023: Diagnosis
https://read.qxmd.com/read/36748332/prior-bexarotene-or-phototherapy-does-not-affect-response-to-chlormethine-gel-post-hoc-analysis-of-a-pivotal-trial
#17
JOURNAL ARTICLE
Chalid Assaf, Christiane Querfeld, Marta Scandurra, Marco Turini, Julia J Scarisbrick
No abstract text is available yet for this article.
February 7, 2023: Acta Dermato-venereologica
https://read.qxmd.com/read/36606565/identifying-unmet-needs-and-challenges-in-the-definition-of-a-plaque-in-mycosis-fungoides-an-eortc-clg-iscl-survey
#18
JOURNAL ARTICLE
P Quaglino, J Scarisbrick, G Roccuzzo, A Abeldano, M Battistella, C McCormack, R Cowan, A Cozzio, J Cury-Martins, P Enz, L Geskin, E Guenova, Y H Kim, R Knobler, I V Litvinov, T Miyagaki, M Molgo, J Nicolay, E Papadavid, L Pinter-Brown, R Pujol Vallverdu, C Querfeld, P Ortiz-Romero, R Stadler, M Vermeer, M Bagot, E Hodak
BACKGROUND: Consensus about the definition and classification of "plaque" in mycosis fungoides is lacking. OBJECTIVES: To delineate a comprehensive view on how the "plaque" entity is defined and managed in clinical practice; to evaluate whether the current positioning of plaques in the TNMB classification is adequate. METHODS: A 12-item survey was circulated within a selected panel of 22 experts (pathologists, dermatologists, hematologists, oncologists), members of the EORTC and International Society for Cutaneous Lymphoma...
January 6, 2023: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/36375717/international-society-for-cutaneous-lymphomas-pandemic-section-iclyps-analysis-of-ctcl-outcomes-during-the-covid-19-pandemic-a-retrospective-cohort-study
#19
JOURNAL ARTICLE
Larisa J Geskin, Bradley D Kwinta, Tiffany J Garcia-Saleem, Oleg E Akilov, Paula Enz, Emmanuella Guenova, Pablo L Ortiz-Romero, Evangelia Papadavid, Pietro Quaglino, Sima Rozati, Connor J Stonesifer, Austin Burns, William S Stringer, Eloy Tarin, Julia J Scarisbrick
No abstract text is available yet for this article.
November 12, 2022: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/36042001/fostering-telecompetence-a-descriptive-evaluation-of-clinical-psychology-predoctoral-internship-and-postdoctoral-fellowship-implementation-of-telehealth-education
#20
JOURNAL ARTICLE
Jonathan G Perle, Alexandria R Perle, David M Scarisbrick, James J Mahoney
PURPOSE: Telehealth education within clinical psychology predoctoral internships and postdoctoral fellowships has become a frequent recommendation designed to prepare future providers with evidence-informed telehealth skills that can be applied to rural populations. Unfortunately, the availability of telehealth training among internships and fellowships, as well as areas for growth, remains unclear. Thus, the current study evaluated graduate clinical psychology internship and fellowship integration of telehealth training components before and after the onset of COVID-19...
August 30, 2022: Journal of Rural Health
keyword
keyword
1926
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.